Shopify’s Billion-Dollar Milestone: Is This a Golden Buying Opportunity?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and payment processor that is used by millions of online merchants worldwide.
Like many tech companies, Shopify has seen its stock price tumble in recent weeks, with the stock’s 30-day losses currently sitting at 27.3%.
With that said, » Read more about: Shopify’s Billion-Dollar Milestone: Is This a Golden Buying Opportunity? »
Read More
Market Commentary: When Will The The Market Top?
Believe it or not you’re about to get a very precise answer to the question when will the market top but, before the entree, a little appetizer.
As we enter year-end, the market has a lot of bullish forces driving it higher, and should continue to support the markets into the new year.
» Read more about: Market Commentary: When Will The The Market Top? »
Read More
Down 30%, Is It Time To Buy This Pharma Giant?
Bristol Myers Squibb (BMY) poses something of a conundrum to investors at the moment. On the one hand, the share price has dramatically underperformed the market, leading to concerns that further declines are on the horizon. And on the other hand, the valuation is starting to look really attractive to bargain hunters.
So,
» Read more about: Down 30%, Is It Time To Buy This Pharma Giant? »
Read More
1 Undervalued Healthcare Stock Flying Under The Radar
Molina Healthcare is not widely known among investors but that may be about to change following 15 quarters straight of year-over-year revenue growth and a member base that has grown to approximately 5.2 million across 20 states as of the most recent quarter.
Strategic moves like acquiring My Choice Wisconsin,
» Read more about: 1 Undervalued Healthcare Stock Flying Under The Radar »
Read More
Tesla’s 40% Drop: Why Bears Say The Worst Is Yet to Come
The recent stock market drop has been a punishing time for the Magnificent Seven tech stocks, and the company hit worst by it has been Tesla (NASDAQ:TSLA).
Shares of the EV manufacturer are down by a jaw-dropping 40 percent in the last three months and 26 percent in the last month alone.
» Read more about: Tesla’s 40% Drop: Why Bears Say The Worst Is Yet to Come »
Read MoreThe Burst
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Spotlight
Spotlight: AI + Robotics = 4x Growth
Google. Apple. Amazon. Microsoft. They are all investing in AI but one company you probably have not heard about is Symbiotic, a warehousing automation firm that combines advanced robotics with artificial intelligence.
It’s one of those businesses that’s hard to wrap your head around at first but it’s been a huge hit on Wall Street.
» Read more about: Spotlight: AI + Robotics = 4x Growth »
Read MoreThe Daily
Tesla Stock Rises Slightly in Premarket Trading
Tesla stock was up 0.5% in premarket trading at $464.22, while S&P 500 and Dow Jones Industrial Average futures were up 0.2% and 0.1%, respectively.
Shares closed at $462.07 on Wednesday, just the seventh time shares have closed above $460. The all-time closing high for Tesla stock is $479.86,
» Read more about: Tesla Stock Rises Slightly in Premarket Trading »